Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. RNR
RNR logo

RNR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Renaissancere Holdings Ltd (RNR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
297.230
1 Day change
0.55%
52 Week Range
315.880
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

RenaissanceRe Holdings Ltd (RNR) is not a strong buy for a beginner investor with a long-term strategy at this time. The stock's valuation appears to have limited upside based on analyst ratings, and recent financial performance shows significant declines in net income and EPS. Additionally, insider selling and neutral hedge fund sentiment suggest caution. While the stock may have potential for recovery in the long term, it does not currently present a compelling entry point.

Technical Analysis

The MACD is negative and contracting, RSI is neutral at 58.361, and moving averages are converging, indicating no strong trend. The stock is trading near its pivot level of 294.958, with resistance at 299.882 and support at 290.034. Overall, the technical indicators suggest a neutral trend with no clear buy signal.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
2
Buy
8

Positive Catalysts

  • NULL identified. No recent news or significant positive developments.

Neutral/Negative Catalysts

  • Insider selling has increased by 432.14% over the last month. Analysts have downgraded the stock citing valuation concerns and pricing pressures in the casualty sector. Financial performance in Q4 2025 showed a significant drop in net income (-477.23% YoY) and EPS (-530.59% YoY).

Financial Performance

In Q4 2025, revenue increased by 3.41% YoY to $2.93 billion, but net income dropped significantly by -477.23% YoY to $739.12 million. EPS also declined by -530.59% YoY to 16.75, indicating a challenging financial period.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are largely neutral on the stock, with multiple firms raising price targets but maintaining Hold or Neutral ratings. Morgan Stanley downgraded the stock to Equal Weight, citing valuation concerns and pricing pressure in the casualty sector. The consensus view suggests limited upside at current valuation levels.

Wall Street analysts forecast RNR stock price to rise
11 Analyst Rating
Wall Street analysts forecast RNR stock price to rise
3 Buy
7 Hold
1 Sell
Hold
Current: 295.590
sliders
Low
267
Averages
308.36
High
455
Current: 295.590
sliders
Low
267
Averages
308.36
High
455
TD Cowen
Hold
maintain
$280 -> $290
AI Analysis
2026-02-26
Reason
TD Cowen
Price Target
$280 -> $290
AI Analysis
2026-02-26
maintain
Hold
Reason
TD Cowen raised the firm's price target on RenaissanceRe to $290 from $280 and keeps a Hold rating on the shares. The firm updated its model following Q4 results.
Morgan Stanley
Overweight -> Equal Weight
downgrade
$310
2026-02-26
Reason
Morgan Stanley
Price Target
$310
2026-02-26
downgrade
Overweight -> Equal Weight
Reason
Morgan Stanley downgraded RenaissanceRe to Equal Weight from Overweight with an unchanged price target of $310. The firm cites valuation for the downgrade with the shares up 32% over the last 12 months. RenaissanceRe's valuation now reflects much of the upside from here, the analyst tells investors in a research note. Morgan Stanley adds that the company faces continued pricing pressure and casualty sector volatility, making a neutral stance more appropriate.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for RNR
Unlock Now

People Also Watch